A groundbreaking shift in Canadian drug policy has taken place, as the regulators announce the availability of psilocybin mushrooms for therapeutic purposes. Previously, these substances were heavily restricted, but a growing body of research suggests they may offer relief for psychological issues like PTSD. This change represents a key step toward